Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

LXRXLXRX
31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in LEXICON PHARMACEUTICALS INC

GEODE CAPITAL MANAGEMENT, LLC holds 6.2M shares of LXRX (LEXICON PHARMACEUTICALS INC), worth $15M as of 2026-Q2. The position was increased (+97.0% shares). LXRX represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$15M

Current Shares

6.2M

Total Value Change

+$11.2M

Total Shares Change

+5.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
6.2M
+97.0%
$15M0.0%$2.40
45
2026-Q1
Increased
3.2M
+26.8%
$4.9M0.0%$1.56
33
2025-Q4
Increased
2.5M
+4.3%
$2.9M0.0%$1.15
27
2025-Q3
Increased
2.4M
+0.8%
$3.2M0.0%$1.35
27
2025-Q2
Decreased
2.4M
-35.5%
$2.2M0.0%$0.95
0
2025-Q1
Increased
3.7M
+4.8%
$1.7M0.0%$0.46
27
2024-Q4
Decreased
3.5M
-0.1%
$2.6M0.0%$0.74
0
2024-Q3
Increased
3.5M
+8.4%
$5.5M0.0%$1.57
29
2024-Q2
Increased
3.3M
+36.0%
$5.5M0.0%$1.68
35
2024-Q1
Increased
2.4M
+1.7%
$5.7M0.0%$2.40
28
2023-Q4
Increased
2.3M
+10.5%
$3.6M0.0%$1.53
29
2023-Q3
Increased
2.1M
+15.5%
$2.3M0.0%$1.09
30
2023-Q2
Increased
1.8M
+6.7%
$4.2M0.0%$2.29
29
2023-Q1
Increased
1.7M
+7.3%
$4.2M0.0%$2.43
29
2022-Q4
Increased
1.6M
+2.5%
$3.1M0.0%$1.91
27
2022-Q3
Increased
1.6M
+17.0%
$3.8M0.0%$2.40
31
2022-Q2
Increased
1.3M
+6.6%
$2.5M0.0%$1.86
28
2022-Q1
Increased
1.3M
+5.0%
$2.6M0.0%$2.09
28
2021-Q4
Increased
1.2M
+0.3%
$4.7M0.0%$3.94
27
2021-Q3
Decreased
1.2M
-6.8%
$5.7M0.0%$4.81
0
2021-Q2
Increased
1.3M
+18.8%
$5.9M0.0%$4.59
32
2021-Q1
Increased
1.1M
+40.1%
$6.3M0.0%$5.87
36
2020-Q4
Decreased
769,588
-0.7%
$2.6M0.0%$3.42
0
2020-Q3
Decreased
774,957
-5.4%
$1.1M0.0%$1.44
0
2020-Q2
Increased
818,875
+19.3%
$1.6M0.0%$2.00
30
2020-Q1
Increased
686,302
+2.4%
$1.3M0.0%$1.95
26
2019-Q4
Decreased
670,137
-0.2%
$2.8M0.0%$4.15
0
2019-Q3
Increased
671,570
+2.9%
$2M0.0%$3.01
27
2019-Q2
Increased
652,982
+4.8%
$4.1M0.0%$6.29
28
2019-Q1
Increased
623,120
+10.3%
$3.5M0.0%$5.56
29
2018-Q4
First report
565,085
-
$3.8M0.0%$6.64
0

Other major holders of LXRX: FMR LLC, BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used